Universität zu Köln

Knop, Viola, Mauss, Stefan, Goeser, Tobias, Geier, Andreas, Zimmermann, Tim, Herzer, Kerstin, Postel, Nils, Friedrich-Rust, Mireen and Hofmann, Wolf Peter (2020). Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy-Results from the German Hepatitis C-Registry. J. Viral Hepatitis, 27 (7). S. 690 - 699. HOBOKEN: WILEY. ISSN 1365-2893

Knop, Viola, Mauss, Stefan, Goeser, Tobias, Geier, Andreas, Zimmermann, Tim, Herzer, Kerstin, Postel, Nils and Hofmann, Wolf Peter (2018). Dynamics of Liver Stiffness By Transient Elastography in Patients with Chronic Hepatitis C (HCV) Infection Receiving Direct Acting Antiviral Therapy-Results from the German Hepatitis C-Registry (DHC-R). Hepatology, 68. S. 424A - 425. HOBOKEN: WILEY. ISSN 1527-3350

Traussnigg, Stefan, Schattenberg, Jorn M. ORCID: 0000-0002-4224-4703, Demir, Muenevver, Wiegand, Johannes, Geier, Andreas, Teuber, Gerlinde, Hofmann, Wolf Peter, Kremer, Andreas E., Spreda, Frank, Kluwe, Johannes, Petersen, Joerg, Boettler, Tobias ORCID: 0000-0002-1195-055X, Halilbasic, Emina, Greinwald, Roland, Proels, Markus, Manns, Michael P., Fickert, Peter and Trauner, Michael H. (2017). norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study. Hepatology, 66. S. 106A - 108. HOBOKEN: WILEY. ISSN 1527-3350

Traussnigg, Stefan, Schattenberg, Jorn M. ORCID: 0000-0002-4224-4703, Demir, Munevver, Wiegand, Johannes, Geier, Andreas, Teuber, Gerfinde, Hofmann, Wolf Peter, Kremer, Andreas E., Spreda, Frank, Kluwe, Johannes, Petersen, Jorg, Boettler, Tobias ORCID: 0000-0002-1195-055X, Rainer, Florian, Halilbasic, Emina, Greinwald, Roland, Prols, Markus, Manns, Michael P., Fickert, Peter and Trauner, Michael ORCID: 0000-0002-1275-6425 (2019). Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial. Lancet Gastroenterol. Hepatol., 4 (10). S. 781 - 794. SAN DIEGO: ELSEVIER INC. ISSN 2468-1253